West Haven, Conn.
NanoViricides is expanding in West Haven, Conn., with the acquisition of an 18,000-sf facility. The building will house laboratories and a cGMP pilot plant for production of nanoviricide pharmaceutical candidates for clinical trials. NanoViricides is engaged in creating anti-viral drugs for H1N1, H5N1, seasonal influenza, hepatitis, rabies, Dengue fever, and Ebola.
